GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT) - ANVISA Registration 80074330013

Access comprehensive regulatory information for GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80074330013 and manufactured by TASCOM CO., LTD. The registration is held by GLOBO REAGENTES E EQUIPAMENTOS P/ LABORATORIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80074330013
Registration Details
ANVISA Registration Number: 80074330013
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80074330013

25351434539202495

02407183000190

Company Information

TASCOM CO., LTD
South Korea
PT: CORÉIA DO SUL

Dates and Status

Jan 27, 2025

VIGENTE

09/18/2025 19:00:01